Your session is about to expire
← Back to Search
Behavioral Intervention
Social Reward Psychotherapy for Suicidal Thoughts
N/A
Recruiting
Led By Nili Solomonov, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, midtreatment (week 6) and post treatment (week 9)
Awards & highlights
Study Summary
This trial will test if a 9-week treatment can improve brain functions and reduce suicidality.
Who is the study for?
This trial is for individuals aged 50-80 with Major Depressive Disorder and suicidal thoughts, who have a certain level of cognitive function (MMSE score within normal range) and are either off antidepressants or on a stable dose. They must not be receiving other psychotherapy, have no plans to change medication doses, and cannot have severe medical conditions or other psychiatric diagnoses that could interfere with the study.Check my eligibility
What is being tested?
'Engage & Connect' Psychotherapy is being tested against Symptom Review and Psychoeducation (SRP) over a 9-week period to see if it improves brain functions related to positive emotions and reduces suicidality in older adults suffering from depression.See study design
What are the potential side effects?
Since this trial involves psychotherapy interventions rather than medications, typical drug side effects are not expected. However, participants may experience emotional discomfort discussing personal issues during therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, midtreatment (week 6) and post treatment (week 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, midtreatment (week 6) and post treatment (week 9)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in STAR task reaction time following social feedback
Change in resting state functional connectivity of the Positive Valence System
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: "Engage & Connect" PsychotherapyExperimental Treatment1 Intervention
Engage & Connect is a remotely-delivered psychotherapy, aimed to increase engagement in rewarding social activities and in turn, reduce suicidality. In Engage & Connect, depressed middle-aged and older adults with suicidal ideation work with a therapist to develop "action plans" to pursue rewarding social activities of their choice.
Group II: Symptom Review and Psychoeducation (SRP)Active Control1 Intervention
In this intervention, the therapist will review the participant's symptoms and provide literature-based clinical explanations and clarifications about the symptoms, the course, and the causes of depression and aging processes. In SRP, the therapist reviews the depressed individual's symptoms, and level of information on depression, identifies misconceptions, and guides selection of educational material which could benefit the patient.
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,581 Total Patients Enrolled
666 Trials studying Depression
251,456 Patients Enrolled for Depression
Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,167 Total Patients Enrolled
66 Trials studying Depression
16,270 Patients Enrolled for Depression
Nili Solomonov, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
120 Total Patients Enrolled
2 Trials studying Depression
120 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I've been on a stable dose of antidepressants for 8 weeks and won't change it.I have a neurological disorder like dementia or Parkinson's.I am able to understand and agree to the research and treatment plan.I take 0.5 mg or less of lorazepam daily, but no other psychotropic drugs.I haven't had a severe illness or major surgery that could affect my participation in the last 3 months.I have been diagnosed with Major Depressive Disorder.My mental function test score is within the normal range for my age and education.I am between 50 and 80 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Symptom Review and Psychoeducation (SRP)
- Group 2: "Engage & Connect" Psychotherapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical investigation accept individuals aged 50 or over?
"Eligibility for this medical trial is restricted to individuals who are between the ages of 50 and 80 years old."
Answered by AI
Might I be permitted to join this clinical experiment?
"In order to meet the eligibility criteria for this investigation, potential participants should suffer from depression and be between 50-80 years old. 128 individuals are currently being sought after in total."
Answered by AI
Is recruitment for this project still underway?
"From what is listed on clinicaltrials.gov, this research project has stopped its recruitment process at the latest update of June 28th 2023. However, there are over 1400 other trials that are accepting subjects at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger